The following products have been found matching your search "his": 437
Or did you mean: FIND ME THIS PAPER Ball et al. (2022): This study highlights the increased incidence of hypoglycemic episodes in diabetic patients, particularly those with Type 1 diabetes, due to disruptions in glucose homeostasis during fasting periods. The study unders | this | sophisticated | his6 | histocompatibility | A client with chronic lymphocytic leukemia (CLL) wants to have treatment for the condition. Which medication will the nurse question for this client? | histogenetically | polymorphisms
No results were found for the filter!
FITC
CyFlow™ CD13 FITC
| Antigen: | CD13 |
| Clone: | WM15 |
| Regulatory Status: | ASR |
| Target Species: | Human |
$410.00 USD
PE
APC
PE-Cy7
CyFlow™ CD13 PE-Cy7
| Antigen: | CD13 |
| Clone: | WM15 |
| Regulatory Status: | ASR |
| Target Species: | Human | Quantity: | 100 tests |
$495.00 USD
PerCP-Cy5.5
CyFlow™ CD123 PerCP-Cy5.5
| Antigen: | CD123 |
| Clone: | 6H6 |
| Regulatory Status: | ASR |
| Target Species: | Human |
$595.00 USD
PerCP-Cy5.5
CyFlow™ CD13 PerCP-Cy5.5
| Antigen: | CD13 |
| Clone: | WM15 |
| Regulatory Status: | ASR |
| Target Species: | Human |
$595.00 USD
FITC
CyFlow™ CD123 FITC
| Antigen: | CD123 |
| Clone: | 6H6 |
| Regulatory Status: | ASR |
| Target Species: | Human |
$410.00 USD
PE-DyLight™ 594
CyFlow™ CD13 PE-DyLight™ 594
| Antigen: | CD13 |
| Clone: | WM15 |
| Regulatory Status: | ASR |
| Target Species: | Human |
$595.00 USD
PE
PE-DyLight™ 594
CyFlow™ CD123 PE-DyLight™ 594
| Antigen: | CD123 |
| Clone: | 6H6 |
| Regulatory Status: | ASR |
| Target Species: | Human |
$595.00 USD